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Abstract
Background: Congenital aniridia caused by heterozygousity at the PAX6 locus is associated with
ocular surface disease including keratopathy. It is not clear whether the keratopathy is a direct
result of reduced PAX6 gene dosage in the cornea itself, or due to recurrent corneal trauma
secondary to defects such as dry eye caused by loss of PAX6 in other tissues. We investigated the
hypothesis that reducing Pax6 gene dosage leads to corneal wound-healing defects. and assayed the
immediate molecular responses to wounding in wild-type and mutant corneal epithelial cells.
Results: Pax6+/- mouse corneal epithelia exhibited a 2-hour delay in their response to wounding,
but subsequently the cells migrated normally to repair the wound. Both Pax6+/+ and Pax6+/- epithelia
activated immediate wound-induced waves of intracellular calcium signaling. However, the intensity
and speed of propagation of the calcium wave, mediated by release from intracellular stores, was
reduced in Pax6+/- cells. Initiation and propagation of the calcium wave could be largely decoupled,
and both phases of the calcium wave responses were required for wound healing. Wounded cells
phosphorylated the extracellular signal-related kinases 1/2 (phospho-ERK1/2). ERK1/2 activation
was shown to be required for rapid initiation of wound healing, but had only a minor effect on the
rate of cell migration in a healing epithelial sheet. Addition of exogenous epidermal growth factor
(EGF) to wounded Pax6+/- cells restored the calcium wave, increased ERK1/2 activation and
restored the immediate healing response to wild-type levels.
Conclusion: The study links Pax6 deficiency to a previously overlooked wound-healing delay. It
demonstrates that defective calcium signaling in Pax6+/- cells underlies this delay, and shows that it
can be pharmacologically corrected. ERK1/2 phosphorylation is required for the rapid initiation of
wound healing. A model is presented whereby minor abrasions, which are quickly healed in normal
corneas, transiently persist in aniridic patients, compromising the corneal stroma.
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The transcription factor PAX6 is required for development
and maintenance of several human ocular tissues, includ-
ing the corneal epithelium. The gene PAX6 was identified
by positional cloning as the defective gene in human ani-
ridia and its associated ocular complications [1-3].
Heterozygous deficiency in PAX6 leads to ocular surface
disease characterized by corneal opacification (aniridia-
related keratopathy; ARK), and the Pax6+/- mouse model
displays all the morphologic defects of human ARK [4-7].
ARK in Pax6+/- mice and humans is characterized by the
presence of thin, fragile vacuolated corneal epithelia [4,6].
There is ingrowth of blood vessels into the cornea, spo-
radic appearance of goblet cells [8,9], and infiltration by
inflammatory cells [10]. The cell biology that links Pax6
dosage to changes in cellular behavior remains poorly
understood. Maintenance of the structural integrity of the
corneal epithelium is essential for corneal transparency.
Impaired re-epithelialization after wounding increases the
risk of infection, exacerbates inflammation, and under-
mines normal stromal remodeling [11]. The cumulative
effect of very small corneal scars following chronic failure
of wound repair may result in loss of transparency. It has
recently been suggested that ARK may be due to corneal
epithelial fragility combined with an abnormal wound-
healing response [12], resulting in degeneration of the
cornea.
Epithelial sheets react to mechanical injuries via a com-
plex process that relies on coordinated proliferation and
migration into the denuded area, matrix deposition and
tissue remodeling [13-16]. Wound-induced migration
and proliferation are regulated by cytokines, extracellular
matrix molecules, and growth factors including insulin-
like growth factor, keratinocyte growth factor, hepatocyte
growth factor and epidermal growth factor (EGF) [17-22].
One of the first reactions to injury of the cell monolayer is
an intracellular calcium rise spreading as a wave from the
injury site to the neighboring cells. This has been reported
in a range of cell systems, mainly in cell lines [23-29]. The
wound-elicited calcium wave stimulates cell proliferation
after injury, and is required for further healing processes
[24]. The intensity of the calcium response quantitatively
controls the subsequent rate of healing in some epithelial
cells, and remodeled calcium signaling may underlie dis-
ease states such as diabetes, hypertension, heart disease,
manic depression and Alzheimer's disease [30-32].
Alongside the calcium wave, the other early response of
epithelial cells to wounding is at least one slower wave of
mitogen-activated protein kinase (MAPK) ERK1/2 phos-
phorylation [33]. The migration of at least some epithelial
cell types appears to be ERK1/2-driven [34]. Addition of
EGF activates ERK1/2 in a 'wild-type' rabbit corneal epi-
thelial cell line [35], and exerts positive effects on epithe-
lial wound healing by promoting migration and mitosis
[17,29,36-38]. In corneal epithelial cells, EGF exhibits a
positive effect on proliferation via orchestrated calcium
influx from intracellular calcium stores and extracellular
space [29,39].
Work by our laboratory and several others have investi-
gated the roles of Pax6 in control of cell adhesion in devel-
opment and disease, but the downstream cell-signaling
pathways have received less attention. We hypothesised
that cell signaling may be faulty. As a model for the reac-
tive cellular pathways that may be controlled by Pax6, we
have developed an in vitro wounding assay for murine pri-
mary corneal epithelial cells and have investigated the
roles of Pax6 in corneal healing. We find that unlike wild-
type, Pax6+/- cells fail to commence healing within the first
2 hours after wounding, and that wound-induced waves
of calcium and phospho-ERK1/2 signaling are required
for rapid response to wounding. Propagation of the
wound-induced calcium wave is defective in Pax6+/- cells,
but addition of EGF restores calcium signaling and pro-
motes ERK1/2 phosphorylation, rescuing their rapid
response to wounding.
Results
Wound healing is delayed in Pax6+/- corneal epithelial 
cultures
The wound-healing response was investigated in primary
murine corneal epithelial cells, cultured as described pre-
viously [40] on plastic or glass on which epithelial cells
could attach and proliferate. All experiments were per-
formed on mouse cells. As shown in Figure 1(A–D),
Pax6+/- and Pax6+/+ cells looked morphologically identical,
although Pax6+/- cultures grew more slowly than wild-type
in the first week after explant, and had multiple defects in
cell-surface glycoproteins, which will be described else-
where (RK, JO, LJL, JMC, manuscript submitted). Epithe-
lial monolayers were strongly positive for nuclear Pax6
staining (Figure 1E), which is required for corneal epithe-
lial development and is a definitive marker for these cells.
In contrast, the widely used human corneal epithelial cell
line (HCE) [29,41,42] was found not to express PAX6
(Figure 1G). Pax6+/- cultures had lower levels of Pax6 pro-
tein than wild-type, assayed both by immunocytochemis-
try (Figure 1K–N) and Western blotting (Figure 1O).
Densitometric analysis of the Western blots (subtracting
background and dividing the intensity of Pax6 staining by
that of β-actin) showed that Pax6+/- cultures had 63% of
the amount of Pax6 produced by wild-type cultures.
Corneal epithelial cultures from Pax6+/+ and Pax6+/- litter-
mates were injured as described in Methods and the rate
of migration into the denuded area measured. All woundsPage 2 of 14
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Morphology and Pax6 expression of cultured corneal epithelial cellsFigure 1
Morphology and Pax6 expression of cultured corneal epithelial cells. (A) Hematoxylin and eosin staining of confluent 
Pax6+/+ and (B) Pax6+/- corneal epithelial cell cultures. Both in confluence and at the outgrowing edge of new cultures (C, D), 
the Pax6+/- cells were morphologically indistinguishable from wild-type. (E) Immunocytochemistry on primary Pax6+/+ mouse 
corneal epithelial cells compared with (G) the human corneal epithelial cell line, HCE. (I) Negative control. (F, H, J) DAPI-
labeled cells. (K, N) Directly comparable Pax6 immunolabelling of Pax6+/+ and Pax6+/- corneal epithelial-cell cultures. (L, N) 
DAPI labeling. (O) Western blot of protein lysate from Pax6+/+ and Pax6+/- corneal epithelial cell cultures probed for Pax6 and 
β-actin. Scale bars = 100 μm.
BMC Biology 2006, 4:27 http://www.biomedcentral.com/1741-7007/4/27healed, and the rates of cell migration were similar to
those observed in vivo (20–50 μm/h) in wild-type rat cor-
neas by Song et al [43]. However, Pax6+/- cultures exhib-
ited a wound-healing delay. Wound healing in the first 2
h after injury was negligible in Pax6+/- cultures (mean ±
SEM 4.4 ± 5.2 μm/h; n = 9) in contrast to Pax6+/+ (28.4 ±
3.8 μm/h; n = 7; Student's t-test: p = 0.0025) (Figure 2).
Interestingly, however, between 2 and 6 hours post-
injury, there was no significant difference in the rate of
healing between Pax6+/- (37.9 ± 4.4 μm/h) cultures com-
pared with Pax6+/+ (53.5 ± 12.5 μm/h; t-test: p = 0.28). The
data suggest that Pax6+/- cells experience a previously
undescribed block that prevents their initial response to
an injury but that they have no intrinsic cell-migration
defect. We know of no other genetic defect that causes a
comparable wound-healing delay.
Calcium response to wounding
No difference was detected in the basal [Ca2+]i levels
between Pax6+/+ and Pax6+/- cultures using Fura-2 probe
(data not shown). The effects of mechanical injury on
intracellular Ca2+ levels were investigated using Fluo-3 flu-
orescent probe. Background images were acquired for
each experiment (Figure 3Ai) prior to injury. Wound size
was approximately 350 μm in diameter, and the wound
area did not differ significantly between experiments.
Immediately after injury (2 seconds), those cells directly
adjacent to the wound edge exhibited a rapid rise in
[Ca2+]i (Figure 3Aii). The Ca2+ response propagated out-
wards to neighboring cells away from the wound edge
(Figure 3Aiii–v). The wave began to diminish within 60
seconds, and [Ca2+]i had returned to basal levels within 3
minutes (Figure 3Avi–vii). The Ca2+ response to injury
was quantified in Pax6+/+ and Pax6+/- cultures (Figure 3B).
The mean changes in fluorescence in cells in the sixth row
from the wound edge were quantified over time. A signif-
icant decrease in both intensity and speed of the Ca2+
wave was observed in Pax6+/- cultures (Figure 3B,C). Inter-
estingly, there was no significant difference in the fluores-
cence intensity in those cells directly adjacent to the
wound between Pax6+/+ and Pax6+/- (row 2, 2 seconds after
wounding), but the intensity of [Ca2+]i was reduced in
cells in row 6, 16 seconds after injury, (Figure 3C; p =
0.01). The peak fluorescence intensity occurred 12 sec-
onds after wounding in Pax6+/+ cells but after 22 seconds
in Pax6+/- cells, and was substantially suppressed in Pax6+/
- cultures (p = 0.013). This is the first demonstration that
changing Pax6 dosage affects calcium signaling in any sys-
tem.
Calcium wave initiation and propagation
The initiation of the calcium wave (the immediate large
calcium rise in cells surrounding the wound) was normal
in Pax6+/- cells, but the propagation was defective. We
showed that the two phases can be decoupled but that
both are required for healing. To investigate the source of
Ca2+ ions involved in the wave that spreads from the
wound edge, we removed Ca2+ independently from the
extracellular and intracellular compartments of Pax6+/+
epithelial cells. Cells were first injured as normal in cal-
cium-free medium. Following injury, those cells directly
adjacent to the wound edge failed to elicit a significant
Ca2+ response (Figure 4A). Wave propagation (at a signif-
icantly reduced intensity and slower speed) was neverthe-
less detectable (Figure 4B) (see Additional files 1 and 2).
Peak fluorescence intensity occurred 60 seconds after
injury in Ca2+-free media compared with 12 seconds for
Pax6+/+ cells in control media.
In separate experiments, intracellular calcium stores were
depleted by 1 μM thapsigargin, which inhibits the
Ca2+ATPase pump of the endoplasmic reticulum. Follow-
ing injury, cells directly adjacent to the wound edge rap-
idly increased [Ca2+]i, but subsequent wave propagation
was prevented (Figure 4A,C; see Additional file 3). Wave
initiation and propagation in murine corneal epithelial
cells can therefore be decoupled. Intracellular Ca2+ is
required only for wave propagation.
When either extracellular calcium or intracellular Ca2+
stores were depleted, both Pax6+/+ and Pax6+/- cells failed
to repair wounds (Figure 4D). The rate of healing in
untreated Pax6+/+ controls was 26.6 ± 1.5 μm/h compared
with 6.3 ± 3.6 μm/h in thapsigargin-treated cultures (t-
test: p < 0.0001) and 8.8 ± 2.9 μm/h in calcium-free media
(t-test, p < 0.0001). Hence, both phases of the Ca2+
response are required for coordinated wound closure.
Propagation is via P2Y receptors, but ATP cannot rescue 
mutant cells
Adenosine triphoshate (ATP) is a potent extracellular sig-
naling molecule involved in cell-cell communication, via
Mean wound-healing rates for Pax6+/+ and Pax6+/- corneal epi-th lial culturesFigure 2
Mean wound-healing rates for Pax6+/+ and Pax6+/- cor-
neal epithelial cultures. Wound healing is divided into an 
initial phase (0–2 hours, black bars), a post-initial phase (2–6 
hours, dark grey) and a mean total over 0–6 hours (pale 
grey). The initial rate of wound healing in Pax6+/- cells is sig-
nificantly lower than that in wild-type (mean ± SEM, * p < 
0.01).Page 4 of 14
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wave, and is released in response to injury in epithelial
cells [29,33]. Pax6+/+ epithelial cells were incubated with
the P2Y receptor inhibitor suramin (100 μM) prior to
mechanical injury. No significant difference was detected
in the Ca2+ response in cells adjacent to the wound edge,
but wave propagation to surrounding cells was inhibited
(Figure 5A,B), suggesting a possible mechanism for wave
progression in response to injury. Addition of 5 μM ATP
alone could induce similar low-intensity Ca2+ waves in
both Pax6+/+ and Pax6+/- cultures, suggesting that P2Y
receptors function normally in mutant cells, and that ATP
release could be the missing factor in the Pax6+/- response
to mechanical injury. However, the addition of ATP 4 sec-
onds prior to wounding in Pax6+/- produced no improve-
ment in the intensity (p = 0.13) or speed of wave
progression (Figure 5C). Peak fluorescence occurred after
22 seconds in untreated Pax6+/- cultures and after 24 sec-
onds in those to which ATP was added. Similarly, 5 μM
ATP made no impact on the rate of wound healing in
Pax6+/- cultures (Figure 5D). This suggests that ATP is not
responsible for the defect in the Ca2+ wave or in wound
healing in Pax6+/- cultures.
EGF can restore the calcium wave and rescue wound-
healing defects
EGF receptors are upregulated following corneal injury
[20,44,45]. We proposed that the EGF response might
mediate the rate of wound healing. We found that 10 ng/
ml EGF elicited a Ca2+ response in our cultures. However,
the rise in Pax6+/- cultures was delayed (mean peak 76 sec-
onds after EGF addition versus 38 seconds in Pax6+/+) and
reduced (Pax6+/- 0.087 ± 0.028% versus Pax6+/+ 0.21 ±
0.03%; p = 0.036, n = 3). Pax6+/- cultures injured in the
presence of 10 ng/ml EGF induced a wave of Ca2+ of
greater intensity than in control Pax6+/- cultures, which
was comparable to the control Pax6+/+ response (Figure
6A; p = 0.667). Furthermore, EGF specifically improved
the initial (0–2 hour) rate of wound healing in Pax6+/-
cells from 6.0 ± 3.7 μm/h to 26.5 ± 5.1 μm/h (p < 0.001)
to a level that was comparable with Pax6+/+ cultures (Fig-
ure 6B). Thus, the addition of EGF to Pax6+/- cells enabled
Mechanical injury induces an intracellular Ca2+ wave in corneal epithelial culturesFigure 3
Mechanical injury induces an intracellular Ca2+ wave in corneal epithelial cultures. (A) (i) Baseline image of Fluo-3 
AM-loaded cells 10 s prior to injury. Scale bar = 50 μm. (ii) Initiation of a Ca2+ wave 2 s after mechanical injury at point marked 
by *. (iii–vii) Wave propagation extended to neighboring cells outwards from the wound edge and diminished to approximate 
basal levels by 150 seconds. Red represents the highest and blue the lowest Ca2+ concentration. (B) Changes in fluorescence 
intensity in cells six rows from the wound edge, expressed as ((F - F0)/F0) × 100 as described in Methods. The average peak flu-
orescence intensity was significantly reduced in Pax6+/- cultures compared with Pax6+/+ (*, p = 0.013) and occurred 12 s after 
injury in wild-type (red arrowhead) compared with 22 seconds in Pax6+/- cultures (black arrowhead). Arrow, wound. (C) No 
significant difference in the intensity was observed in cell row 2 between Pax6+/+ and Pax6+/-. Intensity in cell row 6 was signifi-
cantly lower in Pax6+/- cultures compared with Pax6+/+ cultures (*, p < 0.01).Page 5 of 14
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from responding to a wound and beginning the healing
process, but did not increase the rate of cell migration in
the 'post-initial' 2–6 hour phase of healing.
ERK1/2 response to injury
EGF can activate the intracellular MAP kinase signaling
molecules ERK1/2, which are themselves phosphorylated
in response to injury [33]. Because ERK1/2 signaling has
been shown to be precipitated by calcium influx in epithe-
lial cells [46], the ERK1/2 response was investigated in our
system. We found by immunocytochemistry that corneal
epithelial cells showed dynamic injury-induced phospho-
rylation of ERK1/2 10 minutes after injury, becoming
restricted primarily to the nuclei of cells at the immediate
wound edge within 30 minutes (Figure 7A,B). This
dynamic early wave of ERK1/2 activation, with an initially
cytoplasmic localization, and variation in intensity of
staining along the wound edge, is identical to that seen
previously by others in the MDCK epithelial cell line [34].
Pax6+/- cells also elicited a phospho-ERK1/2 response to
wounding (Figure 7C). Using immunocytochemistry, it
appeared that ERK1/2 phosphorylation in Pax6+/- cells
was stimulated by addition of EGF 90 seconds prior to
wounding. This was confirmed by Western blotting (Fig-
ure 7D,E). EGF had no effect on the levels of Pax6 protein
in cultures, assayed by Western blotting (Figure 7E).
We investigated the requirement for ERK1/2 phosphoryla-
tion for wound healing. Wild-type and Pax6+/- cells were
injured in the presence of 10 μM U0126 to inhibit the
activated ERK1/2 pathway. It was found that addition of
U0126 specifically prevented migration of Pax6+/+ cells
within the first 2 hours after wounding (t-test: Pax6+/+ con-
trols versus Pax6+/+ U0126-treated, p = 0.007; n = 17 con-
trol, 23 drug-treated) (Figure 7C). In contrast, migration
Biphasic calcium response is required for wound healingF gure 4
Biphasic calcium response is required for wound healing. (A) Time-lapse images show wave propagation in response 
to injury in control, calcium-free and 1 μM thapsigargin-treated Pax6+/+ monolayer cultures. Removal of Ca2+ from extracellular 
medium prevented initial rise of [Ca2+]i in cells adjacent to wound but did not prevent propagation of a significantly less intense 
wave. Thapsigargin did not prevent rise of [Ca2+]i in cells immediately adjacent to wound edge but inhibited wave propagation 
(see Additional files 1, 2, 3). (B) Changes in fluorescence intensity in Pax6+/+ cultures in Ca2+-free HBSS in time-lapse images. 
(C) Thapsigargin-treated cultures showed no significant difference in wave initiation (row 2, 6 seconds) compared with Pax6+/
+, but significantly less propagation (row 6) (*p = 0.014). (D) Rate of wound healing in Pax6+/+ and Pax6+/- cultures. Depletion of 
intracellular Ca2+ stores with thapsigargin (T) or incubation in calcium-free medium almost completely inhibited wound healing 
compared with untreated Pax6+/+ controls (*, p < 0.001, n = 6). Scale bars = 50 μm.Page 6 of 14
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ence of U0126 was relatively normal (mean 20.7 μm/h),
although still marginally significantly slower than the
untreated controls (32.4 μm/h; t-test: Pax6+/+ controls ver-
sus Pax6+/+ U0126-treated, p = 0.039; n = 17 control, n =
15 drug-treated) (Figure 7C). To determine whether this
confined effect was caused by degradation of the drug
after the first 2 hours of incubation with the cells, the
experiment was repeated with replacement of the culture
medium with fresh medium containing 10 μM U0126
every 2 hours. This had no additional effect; the rate of
Pax6+/+ cell migration 2–6 hours after wounding with
addition of fresh drug at 2 and 4 hours (21.9 μm/h, n = 8)
was not significantly different that of experimental groups
with a single addition of drug prior to wounding (20.7
μm/h, n = 15, as above; t-test, p = 0.81). Similarly, U0126
had no effect on wound healing by Pax6+/- cells. In the first
2 hours after wounding, untreated cells showed negligible
rates of migration, as described previously, and addition
of 10 μM U0126 did not change that. During hours 2–6
after wounding, U0126-treated Pax6+/- cells healed at 18.1
± 3.30 μm/h, with or without addition of fresh drug –
slower than untreated Pax6+/- controls (34.5 ± 3.57 μm/h)
but not significantly different from drug-treated Pax6+/+
cells (t-test, p = 0.51) (Figure 7D).
EGF addition corrects the wound response in mutantsFigure 6
EGF addition corrects the wound response in 
mutants. (A)Priming Pax6+/- cultures 90 s prior to wound-
ing with 10 ng/ml EGF induced a significantly more intense 
Ca2+ wave that was comparable to Pax6+/+ cultures (p = 
0.667). (B) The initial rate of healing in EGF-treated Pax6+/- 
cultures was restored to wild-type levels, and significantly 
higher than in control Pax6+/- cultures (*, p < 0.001).
Activation of purinergic receptors is necessary but not suffi-cient for w und healing of Pax6+/- epitheliaFigure 5
Activation of purinergic receptors is necessary but 
not sufficient for wound healing of Pax6+/- epithelia. 
(A) Inhibition of purinergic receptors with suramin did not 
prevent rise of [Ca2+]i in Pax6+/+ cells directly adjacent to the 
wound edge 6 seconds after injury (i), but did prevent propa-
gation of the wave to neighboring cells after 16 seconds (ii). 
(B) No significant difference was detected in the intensities 
of the suramin-treated group in row 2, but intensity in row 6 
was significantly reduced (*, p < 0.001). (C) ATP was added 
to cells 4 seconds prior to wounding (indicated by arrow). 
No significant difference in intensity was detected between 
the curves (p = 0.13, n = 12 and 9 respectively). (D) Suramin 
inhibited wound healing in Pax6+/+ cells (*, p < 0.01), but ATP 
did not improve wound-healing rates in Pax6+/- cells. Scale 
bar = 50 μm.Page 7 of 14
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ERK1/2 phosphorylation in wild-type and mutant cultures is required for early wound responseFigure 7
ERK1/2 phosphorylation in wild-type and mutant cultures is required for early wound response. (A–D) Immu-
nolabeling of phospho-ERK1/2, (A) 10 minutes after wounding in Pax6+/+ cultures; (B) 30 minutes after wounding in Pax6+/+ 
cultures and (C) 10 minutes after wounding in Pax6+/- cultures. (D) Exposing Pax6+/- cells to EGF 90 s before wounding elicited 
a large phospho-ERK1/2 response after 10 minutes. In all cases, * indicates the wounded region. Scale bars = 100 μm. (E) 
Western blots of protein lysate of Pax6+/+ and Pax6+/- cultures. The same blot was probed sequentially with antibodies against 
Pax6, phospho-ERK1/2 (P-ERK1/2), and β-actin. Left hand lane: Pax6+/- cultures with 10 minute EGF exposure as described 
above. Middle lane: Pax6+/- cultures with no EGF exposure. Right hand lane: control Pax6+/+ cultures. Correcting for the volume 
of actin staining, phosphor-ERK1/2 staining in control heterozygous cultures was estimated at 80% of wild-type levels. Addition 
of EGF prior to wounding did not change Pax6 levels in Pax6+/- cultures, but increased phospho-ERK1/2 staining to levels com-
parable with or greater than Pax6+/+. All samples were taken from pools of at least six corneal epithelial cell cultures treated 
identically. (F) Rates of wound healing of wild-type and mutant cells with addition of 10 μM U0126 (an inhibitor of phosphor-
ERK1/2 signaling), 0.1% DMSO, 15 minutes prior to wounding (U), or with addition of U0126 prior to wounding and replace-
ment of drug in fresh medium every 2 hours (U*), or Pax6+/+ and Pax6+/- cultures with addition of 0.1% DMSO only. (*, p < 0.01 
compared with wild-type control).
BMC Biology 2006, 4:27 http://www.biomedcentral.com/1741-7007/4/27Consistent with the transient ERK1/2 activation response
to wounding, we conclude that ERK1/2 phosphorylation
within the first 30 minutes is required for the initiation of
cell migration. In the absence of ERK1/2 phosphorylation,
Pax6+/+ cells experience a wound-healing delay, but all
cells, whatever their Pax6 genotype, can overcome this
block and start migration after about 2 hours. It is clear
that there are other signaling systems that can elicit a
wounding response, which were not investigated here.
Discussion
Pax6+/- mice represent an excellent model of human
PAX6+/- aniridia-related keratopathy. Clinically, the symp-
toms of ARK are consistent with an altered wound-healing
response [12]. Pax6 directly binds matrix metalloprotein-
ase-9 (MMP-9, also known as gelB) promoter to upregu-
late MMP-9 in wounded corneas [47]. MMP-9 is one of a
family of proteins required for tissue remodeling during
wound repair. Experiments carried out previously on
intact Pax6+/- corneas suggested in a non-quantitative
manner that Pax6+/- corneas do heal [47,48], but investi-
gated cell migration on a diseased stroma, which may
modulate wound healing [49,50]. The etiology of ARK is
complicated, because anterior eye development is coordi-
nated to some extent by the lens, which is very sensitive to
Pax6 dosage [51], and although the corneal epithelium
expresses high levels of Pax6 throughout life, the stroma
also expresses Pax6 around birth [5,52]. Corneal epithe-
lial dysgenesis in Pax6 mutants might be the result of
intrinsic defects within the epithelial cells themselves or
the fault of defective tissue-tissue interactions in the eye.
The extent to which tissue-tissue interactions contribute to
corneal epithelial dysgenesis can be addressed by isolating
the epithelial cells. If cultured mutant corneal epithelial
cells were phenotypically and molecularly normal, we
would infer that the corneal epithelial defects were sec-
ondary to a problem with Pax6 dosage elsewhere in the
eye. To identify the primary defects that underlie the etiol-
ogy of the disease, we therefore investigated wound heal-
ing in Pax6+/- corneal epithelial primary culture. We
developed and validated an in vitro system for wound
healing in primary murine corneal epithelia. Cells formed
Pax6-positive confluent epithelial sheets, and we demon-
strated that they show physiological calcium and MAPK
responses to injury. The results of the investigation were
surprising, with fundamental implications for the links
between transcription-factor action, cell signaling, cell
behavior, and disease.
Pax6 dosage and wound healing
Pax6+/- corneal epithelial cultures expressed substantial
quantities of Pax6, estimated to be about 60–70% that of
wild-type. Pax6 autoregulates its own expression [53], and
there is no direct 1:1 relationship between Pax6 gene dos-
age and the levels of protein present in the cells [54].
Overexpression of Pax6 in corneal epithelial cells inhibits
cell-cycle progression [55], and the anterior eye is particu-
larly sensitive to dosage of important transcription factors,
with <70–80% or >~150% activity leading to dysgenesis
[56]. Furthermore, corneal epithelial cells are derived
from Pax6-positive stem-like cells in the corneal periphery
(limbal stem cells) [57], and heterozygosity at the PAX6
locus compromises these cells [7] and leads to the produc-
tion of corneal epithelia that may not be fully differenti-
ated [58]. We consider, therefore, that abnormal behavior
of Pax6+/- corneal epithelial cells in culture may relate to a
failure of full differentiation that occurred in vivo days or
weeks before.
We showed that wound healing was delayed for 2 hours
in mutant cells, but that once healing began, the cells
moved as fast as wild-type. Rates of cell migration, at 25–
50 μm/h for wild-type cells, are similar to those obtained
by Song et al for wild-type rat corneas in vivo [43].
While this paper was under review, a new paper [59]
showed that in ex vivo whole-eye culture, Pax6+/- corneas
healed faster than wild-type over a 24-hour period. The
first 2 hours of wound healing were not studied by Ram-
aesh et al [59], levels of Pax6 were not assayed, and the
calcium or MAPK response to wounding in the epithelium
was not studied. As described above, in the whole-eye cul-
ture system, the corneal epithelial migration is modulated
by the presence of an inflamed stroma, which would be
expected to accelerate cell migration over extended peri-
ods of healing. Another important difference between the
experiments is the size of the wounds, which were very
large (1000–1200 μm) in the study by Ramaesh et al [59],
encompassing up to half the cornea and encroaching on
the limbal region. Larger wounds in Pax6+/- corneal epi-
thelia healed faster than smaller wounds (presumably
because larger wounds were closer to the source of prolif-
erating limbal stem cells), and extrapolation from figure 2
in that study [59] suggested that wounds smaller than 500
μm in diameter would heal more slowly than wild-type.
Wounds in our system are smaller and more physiologi-
cal, rarely larger than 200 μm, so there is therefore no
immediate contradiction between our work and this new
study; however, the situation appears to be more compli-
cated than that presented by either paper, and there is
clearly more work needed.
Our data show that there is no defect per se in the ability
of mutant cells to migrate normally, providing they get
the correct signals. The delay in wound healing was, how-
ever, intrinsic to the epithelia, so we investigated the
immediate responses to wound healing in mutant cells.Page 9 of 14
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We are unaware of any other genetic model of epithelial
wound healing where cells appear to fail to sense wounds
initially, but migrate normally once this block is over-
come. The mechanisms underlying this failure have wide
relevance for the understanding of the molecular basis of
the wound-healing response. In this study, it was found
that the delay in Pax6+/-wound healing was associated
with a decrease in the intensity and rate of propagation of
the wound-induced calcium wave. Extracellular calcium
was required for the large initial calcium rise, and intrac-
ellular calcium stores were shown to be essential for wave
propagation. Hence, it is suggested that the failure in
Pax6+/- cells is due to slow or inefficient release of calcium
from stores. It has been shown previously that a quantita-
tive decrease in capacitive calcium entry to wounded gas-
trointestinal mucosal epithelial cells, facilitated by
calcium release from the stores, leads to a quantitatively
reduced healing response [31,32]. We have also found a
consistent link between wound-healing rate and the
intensity and speed of the calcium wave after wounding.
Pharmacological disruption of any aspect of the calcium
wave in Pax6+/+ cells therefore recapitulated a wound-
healing defect (Table 1). Our data strongly support a
model whereby the injury-elicited calcium wave is
required for wound healing [60], and indicate that the
subnormal propagation of the calcium wave in Pax6+/-
corneal epithelia underlies the wound-healing delay.
EGF signaling and the calcium and ERK responses
In gastric mucosal epithelia, extracellular signaling (in this
case, by Sonic hedgehog) elevates intracellular calcium,
which in turn activates ERK, leading to cell proliferation
[46]. The activation of ERK pathways by calcium signaling
in response to extracellular signals has also been observed
in a number of neural cell types [61-63]. Wounding of
both Pax6+/+ and Pax6+/- corneal epithelia elicited ERK1/2
phosphorylation in a dynamic manner around the wound
within 10 minutes. By 30 minutes after wounding, how-
ever, pERK1/2 immunolabeling was restricted primarily
to nuclei of cells immediately adjacent to the wound edge.
The pattern of immunolabeling was identical to that
found previously by Matsubayashi et al [34] upon wound-
ing of MDCK epithelial cells. They showed that inhibition
of the ERK1/2 signalling pathway reduced wound healing
by about 50% in the 6 hours after wounding. We also
found this; over the whole 6 hours of the experiment,
mean ± SEM rate of wound healing of untreated wild-type
cells was 27.6 ± 2.8 μm/h, compared with 13.8 ± 2.2 μm/
h for wild-type cells treated with U0126. However, we
have extended the conclusions of Matsubayashi et al with
a finer temporal assay of rates of wound healing, and
show that although ERK1/2 inhibition does reduce the
rate of cell migration during healing, ERK1/2 phosphor-
ylation is primarily required for the rapid response to
wounding within the first 2 hours.
The distribution of EGFR is abnormal in Pax6+/- corneal
epithelia [6], and our data demonstrate that the calcium
reaction in response to EGF of unwounded Pax6+/- cells is
significantly lower than in Pax6+/+. Addition of exogenous
EGF to wounded Pax6+/- cells enhanced both the wound-
elicited calcium wave and ERK1/2 phosphorylation, and
restored the immediate migration response to wounding
to wild-type levels without affecting the rate of migration.
This suggests that Pax6+/- EGF signaling is defective, per-
haps due to reduced autocrine EGF production or failure
of normal EGFR activity. EGF is known to enhance capac-
itative calcium entry (CCE) in corneal epithelial cells [39].
Because CCE is known to be quantitatively coupled with
the migration speed in mucosal epithelial wound repair
[31,32], this suggests a possible mechanistic explanation
of positive EGF action on the wound-healing rates via cal-
cium in our system.
EGF also acts via ERK1/2 to downregulate Pax6 and pro-
mote proliferation in rabbit corneal epithelial cells
[39,64]. We detected no change in Pax6 levels following
EGF addition to Pax6+/- cells, but this is not inconsistent
with the results of Li and Lu [64], because our study inves-
tigates the cellular responses within the first few minutes
of wounding, whereas changes in Pax6 protein levels
would be expected to take much longer than this. Further-
more, in the present study, it is unlikely that cell prolifer-
ation affects wound-healing rates, because the changes in
cell proliferation take several hours (2–3 days in the study
of Li and Lu [64]). We have detected no difference in 5-
bromodeoxyuridine uptake between primary cultures
with different Pax6 dosages, and very little cell prolifera-
tion is noted in the first 2 h after wounding (Kitazawa et
al [65]; JMC, unpublished observations), whereas Pax6+/+
cells, and Pax6+/- cells with exogenous EGF, begin to
migrate within the first few minutes. Our data suggest that
Table 1: Calcium response, genotype and wound healing.
High [Ca]i Healing
Initiation Propagation 0–2 h 2–6 h
Pax6+/+ +++ +++ +++ +++
No Ca2+o - + - -
No Ca2+i +++ - - -
No P2Y +++ - - -
+ ATP +++ +++ +++ +++
Pax6+/- +++ + - +++
Pax6+/- + ATP +++ + - +++
Pax6+/- + EGF +++ +++ +++ +++
+++, normal wild-type control response; +, subnormal response; -, 
response not detectable.Page 10 of 14
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Wound healing in Pax6+/- corneas
Based on our data, we divide wound healing into an
immediate period of 2 hours when calcium and MAPK
signaling occur to initiate a rapid migratory response, and
the subsequent 'post-initial' coordinated movement of
epithelial sheets when cell migration is maintained. In the
hours subsequent to this, cell proliferation is initiated;
this last process is also modulated by Pax6 and the role of
Pax6 in this regard has been studied previously [64].
We propose a model, based on our data combined with
previous studies cited earlier, which postulates that Pax6
dosage does not affect the rate of corneal epithelial cell
migration per se on a neutral substrate. In contrast, the pri-
mary defect of the Pax6+/- corneal epithelium is the initial
failure to respond to wounding. We have shown that
upon wounding a corneal epithelium, external calcium
enters cells around the wound, and this is quantitative
similar in both wild-type and Pax6+/- cells. Further propa-
gation of calcium rise to cells away from the wound is
required for the wound response, which is realized by cell-
cell signaling via P2Y receptors and involves predomi-
nantly calcium from intracellular stores. We have shown
that this process is inefficient in Pax6+/- cells, and that sec-
ondary messenger ERK1/2 signaling pathways must also
be activated following wounding to initiate immediate
cell migration. Calcium signaling occurs in the first 2 min-
utes, whereas ERK1/2 signaling is expected to peak about
3–10 minutes after wounding [34]. Both calcium and ERK
responses are sensitive to EGF, which is present in tears at
1–10 ng/ml [66], and we show that calcium response to
EGF is diminished in heterozygotes (possibly due to mis-
localisation of EGFR in the mutant epithelium [6]).
Together, these cell-signaling problems decelerate the
response of mutant cells to small physiological wounds.
In vivo, the chronic delay in sealing small holes caused by
minor abrasion or other cell loss may be sufficient to
allow the corneal stroma to become compromised, lead-
ing to opacity. We therefore link a transcription factor
mutation, via defects in calcium signaling, to a cellular
abnormality that underlies human disease.
Microarray study in the lens suggested that as many as
5000 genes may be regulated by Pax6 [67]. It was perhaps
expected therefore that the links between Pax6 and cell
behavior would be pleiotropic, with a complex etiology
intractable to mechanistic investigation. Our data suggest,
however, that this is not the case, and that the link
between genetics of disease and pharmacological correc-
tion (in this case via EGF) may not be so esoteric.
Wound healing is in part a recapitulation of important
developmental pathways, [68] and it is very likely that the
genetic pathways investigated here recapitulate genetic
pathways that are controlled by Pax6 during develop-
ment. We hypothesize that in other organ systems where
Pax6 and calcium signaling are both known to be
required, such as axon guidance [69,70], Pax6 dosage may
directly control the kinetics of the calcium response of
cells to their external environment.
Conclusion
Propagation of wound-induced signaling via calcium
release from intracellular stores is inefficient in Pax6+/- cor-
neal epithelial cells, and this underlies an intrinsic
wound-healing delay. Pax6 dosage does not, however,
affect the rate of cell migration in healing epithelia, 2–6
hours after wounding. MAP kinase signaling via phospho-
rylation of ERK1/2 is required for the immediate wound-
healing response, but has only a marginal effect on the
rate of cell migration in a healing epithelium. Addition of
EGF prior to wounding rescues the calcium response in
mutant cells and exaggerates the levels of ERK1/2 phos-
phorylation, restoring rapid wound-induced cell migra-
tion. Failure to respond quickly to minor wounding in
fragile Pax6+/- corneal epithelia could lead to the observed
chronic corneal degeneration in patients, but our data
suggest that pharmacological manipulation of the EGF
pathway is a potential therapeutic strategy.
Methods
Mice and cell culture
Pax6+/Sey-Neu (Pax6+/-) mice [71] were maintained on the
CBA/Ca genetic background by heterozygous mating.
Corneas were dissected from Pax6+/+ and Pax6+/- litterma-
tes 8–10 weeks old. A small proportion of heterozygous
corneas were rejected for use because they exhibited severe
ocular surface damage. Previous work had demonstrated
that adult murine Pax6+/- corneal epithelia are cytokeratin-
12-positive with only minor incursion of goblet cells, and
no other conjunctival contamination was detected [58].
Studies were performed using primary monolayer corneal
epithelial cells. Corneas were isolated and cultured
according to the method of Hazlett et al [40]. Central cor-
neal buttons, free of conjunctival cells, were washed in
phosphate-buffered saline (PBS) containing 500 U/ml
penicillin G and 500 μg/ml streptomycin for 10 minutes
and transferred to 35-mm plastic dishes or glass coverslips
as appropriate, epithelium-side up, for 5 minutes before
addition of complete culture medium (15 ml keratinocyte
basal medium (Cambrex, UK), 19 ml DMEM:F12, 5 ml
fetal bovine serum (12.5% v/v), 125 μg/ml gentamycin,
125 μM 2-β-mercaptoethanol and 25 mM HEPES). The
corneal explant was removed after 14 days and cultures
were used 2–3 days later. Corneal epithelial cells culturedPage 11 of 14
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be very similar to fresh corneal epithelia, and express
major corneal epithelial markers [40].
Chemicals and reagents
Thapsigargin and suramin were from Calbiochem (Not-
tingham, Nottinghamshire, UK); MEK inhibitor U0126
from Promega (Southampton, Hampshire, UK); EGF and
ATP from Sigma-Aldrich (Poole, Dorset, UK); anti-phos-
pho-ERK1/2 from NE Biolabs (Hitchin, Hertfordshire,
UK). Anti-Pax6 monoclonal antibody developed by A.
Kawakami was obtained from the Developmental Studies
Hybridoma Bank developed under the auspices of the
NICHD (University of Iowa, IA, USA). Fluorescent probes
were from Invitrogen (Paisley, UK).
Ca2+ imaging
Calcium imaging was performed in modified Hanks' bal-
anced salt solution (mHBSS; 2.5 mM CaCl2, 150 mM
NaCl, 4 mM KCl, 1 mM MgCl2, 10 mg/ml D-glucose, 20
mM HEPES). For experiments in Ca2+-free medium, the
CaCl2 was replaced with 1 mM EGTA.
Murine corneal epithelial cells grown on glass coverslips
were incubated for 45 minutes in mHBSS with 8.8 μM
Fluo-3 AM in dimethyl sulfoxide (final concentration
0.2%) and Pluronic F-127 (final concentration 0.02%).
Drugs were preincubated with the cells in mHBSS during
the Fluo-3 incubation. Cells were washed twice with
mHBSS (Ca-free or with drugs when appropriate) and
positioned on a Zeiss Axiovert S100T microscope with a
100-W mercury arc lamp, a cooled CCD camera (Quantix,
Photometrics) and 10 × objective. For excitation, an FITC
filter (480/30 nm) was used. No emission filter was used.
Images were captured at least 15 seconds before injury (an
approximately circular wound using a 3G needle) to
establish the baseline of fluorescence reading at 2-second
intervals for 180 seconds. For experiments in which EGF
was added prior to wounding, imaging started 70 seconds
after EGF addition, and the cells were injured after further
20 seconds.
Image analysis
Ca2+ dynamics were evaluated using the changes in fluo-
rescence intensity of calcium probe Fluo-3. MetaMorph
(Universal Imaging Corp.) and Image J http://
rsb.info.nih.gov/ij/ software were used. The data are pre-
sented as percentage change in the fluorescence intensity
at each time point (F) to the first time point (F0) reading;
the term ((F - F0)/F0) × 100 was used to represent this per-
centage change. In captured images, the second and sixth
cell rows from the wound edge were drawn. The second-
row intensity was assessed in order to study the calcium
dynamics in cells adjacent to the wound. The first cell row
on the wound edge was not evaluated because it included
damaged cells. The fluorescence intensity of the sixth cell
row was used to investigate the spread of calcium waves
from the wound edge into the neighboring tissue.
Rate of wound healing in epithelial cultures
Small wounds were introduced into confluent Pax6+/+ and
Pax6+/- monolayers in 35-mm dishes using a fire-polished
glass pipette. The initial wound size and shape were simi-
lar and therefore shared the same mechanistic features in
healing. The distance across each wound in four places
was measured using calibrated eyepiece graticules every
hour for 6 hours or until wounds were completely closed.
Cells were incubated at 37°C, 5% CO2 at all times. Rate of
wound healing was expressed in μm/h.
For inhibition of phospho-ERK1/2 signaling, 10 μM
U0126 (made up as a 10 mM solution in DMSO) was
added to the cells in culture 15 minutes before wounding
unless stated otherwise.
Immunocytochemistry
Cultures were fixed in PBS containing 4% w/v paraformal-
dehyde, permeabilised in methanol for 10 minutes at -
20°C, and rinsed three times with PBS before blocking for
30 minutes (blocking buffer: 0.3% BSA, 4% normal goat
serum, PBS). Cells were incubated in primary antibody
(Pax6 diluted 1:50, Phospho-ERK1/2 diluted 1:300, both
in blocking buffer) overnight at 4°C. After three 5-minute
washes in PBS, secondary antibody (Alexa fluor 488 goat
anti-mouse, 1:200 in blocking buffer) was added for 1
hour. Following three 5-minute washes in PBS, cells were
mounted in Vectashield (Vector Laboratories).
Statistical analysis
Unpaired Student's t-test was used for assessment of sig-
nificance of differences between groups. The non-para-
metric Mann-Whitney test was used when the standard
deviations of compared groups were significantly differ-
ent.
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Calcium signalling in control wounded corneal epithelium Fluo-3 
imaging of intracellular calcium after wounding. Total length of video 
represents 2 minutes, red represents the highest calcium concentration, 
blue/violet the lowest. The wave initiates strongly at the wound edge and 
travels into the epithelial sheet.




Calcium signalling in Pax6+/+ corneal epithelium wounded in cal-
cium-free medium Fluo-3 imaging of intracellular calcium after wound-
ing in calcium-free HBSS. Total length of video represents 2 minutes, red 
represents the highest calcium concentration, blue/violet the lowest. There 
is no strong calcium response immediately adjacent to the wound edge, but 
a weak calcium wave is visible that propagates from the wound edge into 
the tissue.




Calcium signalling in Pax6+/+ corneal epithelium wounded in the 
presence of thapsigargin. Fluo-3 imaging of intracellular calcium after 
wounding. Total length of video represents 2 minutes, red represents the 
highest calcium concentration, blue/violet the lowest. The wave initiates 
strongly at the wound edge but fails to propagate into the epithelial sheet.
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